Loading...
OTCMIQAIF
Market cap3mUSD
May 22, Last price  
0.02USD
Name

IQ-AI Ltd

Chart & Performance

D1W1MN
OTCM:IQAIF chart
P/E
P/S
5.60
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
14.43%
Rev. gr., 5y
29.87%
Revenues
609k
+13.72%
35,768,00036,258,00042,368,00046,266,00042,547,00029,409,0006,043,0005,052,000105,00078,00076,000000164,971267,868255,314521,069535,886609,390
Net income
-624k
L+19.43%
4,425,0004,213,0004,013,0003,282,000-12,213,0002,597,000-394,000-9,025,000111,000-1,261,000-1,771,000-153,000-303,000-281,000-764,080-667,629-749,346-511,768-522,311-623,816
CFO
-97k
L-74.16%
3,715,0006,614,0002,907,0003,947,00082,0003,703,0001,144,000-2,158,000-5,446,000-651,000-272,000-283,000-256,000-211,000-683,673-524,610-423,222-288,759-374,671-96,829

Profile

IQ-AI Limited, through its subsidiaries, develops software applications for the healthcare industry in Jersey and the United States. Its products include IB Clinic, a toolkit of post-processing software plug-ins for integrating into existing medical image visualization applications; IB Rad Tech, a workflow engine that processes customized workflows; IB Neuro, which analyzes MR data sets and generates parametric perfusion maps quantifying changes in contrast over time; and IB Delta Suite that performs a various fundamental radiology operations, including image co-registration, subtraction, class map generation, and export. The company also offers IB DCE, which analyzes conventional T1 weighted images and generates an array of relevant perfusion and permeability parameters; IB Diffusion that analyzes MR diffusion-weighted images and generates apparent diffusion coefficient, extrapolated b-value, IVIM, and other parameter maps; and IB StoneChecker, a medical software tool to aid clinical decision making by providing information about a patient's kidney stone. In addition, it provides consulting services. The company was formerly known as Flying Brands Limited and changed its name to IQ-AI Limited in October 2018. IQ-AI Limited is based in Saint Helier, Jersey.
IPO date
Mar 15, 1996
Employees
6
Domiciled in
JE
Incorporated in
JE

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
609
13.72%
536
2.84%
521
104.09%
Cost of revenue
1,016
1,037
1,011
Unusual Expense (Income)
NOPBT
(406)
(501)
(490)
NOPBT Margin
Operating Taxes
11
11
Tax Rate
NOPAT
(406)
(512)
(501)
Net income
(624)
19.43%
(522)
2.06%
(512)
-31.70%
Dividends
Dividend yield
Proceeds from repurchase of equity
595
BB yield
-5.74%
Debt
Debt current
62
55
Long-term debt
218
Deferred revenue
Other long-term liabilities
(156)
Net debt
(139)
(34)
(673)
Cash flow
Cash from operating activities
(97)
(375)
(289)
CAPEX
(40)
(57)
Cash from investing activities
(78)
(40)
(57)
Cash from financing activities
595
FCF
55
(511)
(504)
Balance
Cash
139
314
729
Long term investments
Excess cash
108
287
703
Stockholders' equity
(20,460)
(20,224)
(19,517)
Invested Capital
20,555
20,993
20,763
ROIC
ROCE
EV
Common stock shares outstanding
183,700
182,610
172,757
Price
0.05
157.53%
0.02
-69.58%
0.06
-41.46%
Market cap
8,634
159.07%
3,333
-67.85%
10,365
-31.68%
EV
8,495
3,299
9,692
EBITDA
(291)
(360)
(357)
EV/EBITDA
Interest
10
11
11
Interest/NOPBT